- Home
- SPRU vs VERU Comparison
SPRU vs VERU Comparison
Compare SPRU & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRU
- VERU
- Stock Information
- Founded
- SPRU 2008
- VERU 1971
- Country
- SPRU United States
- VERU United States
- Employees
- SPRU N/A
- VERU N/A
- Industry
- SPRU Auto Parts:O.E.M.
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- SPRU Consumer Discretionary
- VERU Health Care
- Exchange
- SPRU Nasdaq
- VERU Nasdaq
- Market Cap
- SPRU 48.7M
- VERU 54.6M
- IPO Year
- SPRU N/A
- VERU 1990
- Fundamental
- Price
- SPRU $2.91
- VERU $3.50
- Analyst Decision
- SPRU
- VERU Strong Buy
- Analyst Count
- SPRU 0
- VERU 3
- Target Price
- SPRU N/A
- VERU $33.33
- AVG Volume (30 Days)
- SPRU 129.1K
- VERU 143.2K
- Earning Date
- SPRU 11-07-2025
- VERU 12-15-2025
- Dividend Yield
- SPRU N/A
- VERU N/A
- EPS Growth
- SPRU N/A
- VERU N/A
- EPS
- SPRU N/A
- VERU N/A
- Revenue
- SPRU $98,396,000.00
- VERU $16,886,419.00
- Revenue This Year
- SPRU $2.12
- VERU N/A
- Revenue Next Year
- SPRU N/A
- VERU N/A
- P/E Ratio
- SPRU N/A
- VERU N/A
- Revenue Growth
- SPRU 23.43
- VERU 337.24
- 52 Week Low
- SPRU $1.13
- VERU $2.64
- 52 Week High
- SPRU $3.41
- VERU $14.20
- Technical
- Relative Strength Index (RSI)
- SPRU 58.25
- VERU 41.79
- Support Level
- SPRU $2.57
- VERU $3.69
- Resistance Level
- SPRU $2.80
- VERU $3.99
- Average True Range (ATR)
- SPRU 0.25
- VERU 0.31
- MACD
- SPRU -0.05
- VERU -0.12
- Stochastic Oscillator
- SPRU 40.49
- VERU 0.00
About SPRU Spruce Power Holding Corporation
Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.